A quarter of hospital MRSA bacteraemia occurs in new arrivals

September 08, 2005

One in four cases of MRSA blood stream infection in hospital occur in patients who have just arrived from the community. These patients tend to be older and have been in hospital before.

These results, published on bmj.com today, should help to refine infection control policies in UK hospitals.

In the past 10 years, MRSA infection has increased in the United Kingdom. The bacterium can infect many sites; one serious form of infection is that in which blood-stream infection occurs (bacteraemia). A national surveillance scheme counts MRSA bacteraemia by hospital trust, but it has not yet addressed whether cases of MRSA bacteraemia are arriving in hospitals from the community.

Researchers at the University of Oxford analysed methicillin resistant Staphylococcus aureus (MRSA) and methicillin sensitive Staphylococcus aureus (MSSA) bacteraemia in patients on arrival in two Oxfordshire hospitals over a seven year period (1997 to 2003).

At one hospital, patients admitted from the community accounted for 49% of total MSSA cases and 25% of total MRSA cases. The proportion of methicillin resistance among patients admitted with Staphylococcus aureus bacteraemia, rose from 14% in 1997 and 1998 to 26% in 2003.

Most patients (at least 91%) admitted with MRSA bacteraemia had previously been in hospital, half had never had MRSA detected before, and 70% were admitted to emergency medical and surgical services. A similar pattern was observed in the other hospital.

Despite some study limitations, the authors conclude that, of the cases of MRSA bacteraemia detected in hospital, a quarter occurs in patients who have just arrived from the community, and that this proportion is increasing. They call for additional research to be undertaken into the best way to recognise these patients.


Related MRSA Articles from Brightsurf:

Widely available antibiotics could be used in the treatment of 'superbug' MRSA
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute.

Computer model shows how to better control MRSA outbreaks
A research team led by scientists at the Columbia University Mailman School of Public Health report on a new method to help health officials control outbreaks of methicillin-resistant Staphylococcus aureus, or MRSA, a life-threatening antibiotic-resistant infection often seen in hospitals.

Using MRSA's strength against it
MRSA evolved to become a deadly killer because it's wily and resilient.

Livestock-associated MRSAfound among MRSA from humans
The survey results show more frequent detections and geographical dispersion of LA-MRSA in humans in the EU/EEA since 2007, and highlight the public health and veterinary importance of LA-MRSA as a 'One Health' issue.

Fighting MRSA with new membrane-busting compounds
Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA).

Know thy enemy: Kill MRSA with tailored chemistry
UConn medicinal chemists have developed experimental antibiotics that kill MRSA, a common and often deadly bacteria that causes skin, lung, and heart infections.

MRSA uses decoys to evade a last-resort antibiotic
The superbug MRSA uses decoys to evade a last-resort antibiotic, reveals new research.

Scientists find a salty way to kill MRSA
Scientists have discovered a new way to attack Staphylococcus aureus bacteria.

Experimental antibiotic treats deadly MRSA infection
A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA.

OU team develops new antibiotic to fight MRSA
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.

Read More: MRSA News and MRSA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.